RSV vaccine in pregnancy: what parents of newborns should know

Respiratory syncytial virus, or RSV, is a common cold-like virus that can be much more serious for babies, especially in the first months of life. For U.S. families, CDC says there are two main ways to help protect infants: a maternal RSV vaccine during pregnancy or an RSV monoclonal antibody given to the baby after birth. ([cdc.gov](https://www.cdc.gov/vaccines/hcp/by-disease/rsv.html))

The practical question is not whether one option is always better. It is which option fits the pregnancy timing, the baby’s birth timing, and whether a pregnant person already received RSV vaccine in a prior pregnancy. CDC says only Pfizer’s Abrysvo is recommended in pregnancy, and it is used in a specific late-pregnancy window. ([cdc.gov](https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html))

The two RSV protection paths

CDC recommends a single dose of Abrysvo for pregnant people at 32 weeks and 0 days through 36 weeks and 6 days of gestation, given seasonally in most of the continental United States from September through January. The goal is to help protect babies from severe RSV during the first months after birth, when they are too young to get their own vaccine protection. ([cdc.gov](https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html))

The other option is infant immunization with a long-acting RSV monoclonal antibody, such as nirsevimab. CDC recommends that route for babies when maternal vaccination was not given, is unknown, or was given too close to delivery to be expected to help. CDC also says babies whose mothers already received maternal RSV vaccine in a previous pregnancy should get the infant antibody instead of another maternal RSV vaccine dose. ([cdc.gov](https://www.cdc.gov/vaccines/hcp/by-disease/rsv.html))

Why only Abrysvo in pregnancy

CDC’s pregnancy guidance is specific: Abrysvo is the only RSV vaccine that may be given during pregnancy. Other RSV vaccines, including GSK’s Arexvy and Moderna’s mResvia, should not be administered in pregnancy. That matters because readers may see several RSV products in the news and assume they are interchangeable. ([cdc.gov](https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html))

In plain language, the recommendation is not “any RSV vaccine in pregnancy,” but one specific product, at one specific time in pregnancy, during the usual RSV season. ([cdc.gov](https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html))

What CDC says about safety monitoring

CDC says clinical trials for maternal RSV vaccine found more preterm births in the vaccine group, but the increase was not statistically significant. Because of that signal, FDA limited use in pregnancy to the later 32-to-36-week window to reduce the chance of exposure earlier in pregnancy. ([cdc.gov](https://www.cdc.gov/vaccine-safety/vaccines/rsv.html))

CDC also says follow-up safety monitoring has been reassuring so far. Early Vaccine Safety Datalink findings from the first season of use did not show an increased risk of preterm birth or babies being small for their gestational age after vaccination at 32 through 36 weeks. Still, CDC says studies continue to look more closely at possible risks such as preeclampsia and preterm birth, so the safety picture is being monitored rather than treated as closed. ([cdc.gov](https://www.cdc.gov/vaccine-safety/vaccines/rsv.html))

Why this matters for families

Preterm birth matters because babies born too early have higher risks of death and disability, and CDC says preterm birth affected about 1 of every 10 U.S. infants in 2022. Babies born very early are also more likely to have breathing and feeding problems and may need more medical care after birth. ([cdc.gov](https://www.cdc.gov/maternal-infant-health/preterm-birth/index.html))

That is part of why RSV prevention is being handled with two overlapping tools instead of one. The aim is to give families protection without missing the narrow window when a baby is most vulnerable. ([cdc.gov](https://www.cdc.gov/vaccines/hcp/by-disease/rsv.html))

Questions to ask your obstetric or pediatric clinician

Am I in the recommended pregnancy window for Abrysvo?
Is it RSV season where I live, and does that change timing?
If I got RSV vaccine in a previous pregnancy, does my baby need the monoclonal antibody instead?
If my baby is born before protection has had time to transfer, what is the backup plan?
Will my insurance cover the vaccine or infant monoclonal antibody, and where should it be given?

Families may also want to ask whether their hospital, OB practice, or pediatric office stocks the product they need, since access and coverage can vary by setting and plan. CDC’s 2026 RSVVaxView dashboard shows maternal RSV vaccination remains an active public-health topic, but it does not by itself determine what any one family should do. ([cdc.gov](https://www.cdc.gov/rsvvaxview/dashboard/pregnant-women-coverage.html))

The bottom line

For most pregnant people, the question is not simply whether to get an RSV vaccine. It is whether the pregnancy falls in the recommended window for Abrysvo, or whether the baby should instead receive an RSV monoclonal antibody after birth. CDC’s current guidance makes timing, eligibility, and prior maternal vaccination the key decision points. ([cdc.gov](https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html))

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.